Navigation Links
Genomatica and DuPont Tate & Lyle Bio Products Successfully Produce 1,4-Butanediol (BDO) on Commercial Scale
Date:2/12/2013

LOUDON, Tenn. and SAN DIEGO, Cal. (PRWEB) February 12, 2013

Genomatica and DuPont Tate & Lyle Bio Products Company, LLC (DT&L) announced the first successful commercial- scale production of 1,4-Butanediol (BDO) using a bio-based manufacturing process. BDO is an intermediate chemical used in a wide variety of applications including athletic apparel, electronics and automotive applications. This campaign, which spanned five weeks in late 2012, produced more than five million pounds (over 2,000 metric tons) of BDO by direct fermentation using conventional sugars as feedstock. This marks the first time that BDO– with an existing worldwide market of billions of pounds per year – has been produced biologically on this scale and at this rate. This campaign was completed less than five years from when Genomatica first demonstrated the ability for a microorganism to produce BDO in 2008.

“This was a sizable commercial-scale production campaign,” said Christophe Schilling, Genomatica’s Chief Executive Officer. “Partnering with DuPont Tate & Lyle brought us biochemical process know-how at significant scale to make the leap from demonstration to commercial volumes. The success of this campaign is a significant milestone for our technology and for the biochemical industry.”

DuPont Tate & Lyle has been running its leading-edge biochemical plant in Tennessee since 2006, producing 1,3-propanediol (PDO) at commercial volumes. The collaboration with Genomatica utilized DuPont Tate & Lyle’s commercial-scale batch fermentation operation to feed the plant’s continuous downstream processing.

“Utilizing Genomatica’s developments, we demonstrated the flexibility of our bioprocessing capability,” said Todd Sutton, president, DuPont Tate & Lyle Bio Products. “We congratulate the Genomatica team on the development of their BDO technology and look forward to continued collaboration.”

The accomplishments of the campaign achieved through this collaboration built on the successful demonstration-scale production of BDO previously confirmed in Decatur, IL by the teams at Genomatica and Tate & Lyle using Genomatica’s proprietary BDO process.

About Genomatica
Genomatica is a widely-acknowledged technology leader for the chemical industry. It delivers new manufacturing processes that enable its partners to produce high-volume intermediate and basic chemicals from renewable feedstocks. Genomatica’s processes are designed to achieve better economics with enhanced sustainability and a smaller environmental footprint than petroleum-based manufacturing processes. Genomatica is developing a pipeline of manufacturing processes for the production of these chemicals, and successfully achieved commercial-scale production of BDO using its process starting in November 2012, ahead of schedule. Genomatica’s accomplishments have been recognized with numerous awards, including the Wall Street Journal Technology Innovation award, ICIS Top 40 ‘Ones to Watch’, the EPA Presidential Green Chemistry Challenge Award, voted #1 Hottest two years in a row by Biofuels Digest, and being named a Best Place to Work by The Scientist.

About DuPont Tate & Lyle Bio Products Company, LLC
DuPont Tate & Lyle Bio Products is a joint venture between DuPont, a global science company, and Tate & Lyle, a world-leading renewable food and industrial ingredients company. DuPont Tate & Lyle Bio Products provides natural and renewably sourced ingredients that do not compromise product performance. For more information on the company’s products, visit http://www.duponttateandlyle.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10419600.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
2. DuPont Pioneer Launches Next Generation T Series Soybeans
3. DuPont, American Farm Bureau Foundation Invests $250,000 in My American Farm Web Education Program
4. DuPont Tate & Lyle Bio Products Announces Innovation Award Program
5. DuPont Congratulates David Hula for Highest Overall Yield with Pioneer® hybrid – P2088YHR in 2012 NCGA Corn Yield Contest
6. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
7. DuPont Leader Overviews 2012 Seed Research Pipeline with Investors
8. Plunketts Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
9. Plunketts Biotech & Genetics Industry Trends & Statistics 2013: A Summary Version of Plunketts Biotech & Genetics Industry Almanac 2013
10. Strand Raises Series B From Burrill & Company
11. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Aratana Therapeutics, Inc. (NASDAQ: PETX ... development and commercialization of innovative biopharmaceutical products for companion ... North America 2016. ... on the FDA approval of three innovative therapeutics in ... (capromorelin oral solution) and NOCITA ® (bupivacaine liposome ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017  ArmaGen, ... Mathias Schmidt , Ph.D., as chief executive officer, ... of directors. Dr. Schmidt brings to ArmaGen more than ... the research and development of biotherapeutics and pharmaceuticals. ... executive with the diverse experience and skillset necessary ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The biometric vehicle access system market, in terms ... from 2016 to 2021. The market is estimated to be USD ... by 2021. The growth of the biometric vehicle access system market ...
(Date:12/15/2016)... --  WaferGen Bio-systems, Inc. (NASDAQ: WGBS ... that on December 13, 2016, it received a letter ... Market LLC which acknowledged that, as of December 12, ... had been at $1.00 or greater for ten consecutive ... Rule 5550(a)(2) of the Nasdaq Stock Market. ...
Breaking Biology News(10 mins):